<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-73061</identifier>
<setSpec>0014-2565</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Lymphocytic variant of the hypereosinophilic syndrome</dc:title>
<dc:description xml:lang="en">Objectives. Hypereosinophilic syndromes (HSS) are a rare group of heterogeneousdisorders characterized by prominent and persistent eosinophilia and organ dysfunction.Secondary causes of eosinophilia must be excluded. Recent advances in molecular biologyand cytogenetics have permitted the characterization of different subsets of hypereosinophilicsyndrome. We describe a patient with the lymphocytic variant. Patient. A 46-year old male Philippine patient presented skin lesions, fever, red eyes,enlarged lymph nodes and marked eosinophilia.Results. Lymphocytic phenotyping by flow cytometry analysis was performed on peripheralblood and an aberrant population of T lymphocytes CD3-CD4+ producing interleukin 5 wasfound. TCR gene rearrangement using PCR amplification confirmed T cell clonality.Conclusions. The lymphocytic variant of the hypereosinophilic syndrome is a primitivelymphocytic disorder characterized by a non-malignant T cell population expansionproducing eosinophilopoietic cytokines, with an indolent clinical course but that cantransform into a peripheral T lymphoma. We report the first case of such a variantpublished in our country and review the characteristics of this variety(AU)</dc:description>
<dc:creator>Perales Fraile, I</dc:creator>
<dc:creator>Citores Sánchez, M. J</dc:creator>
<dc:creator>Masip Marzá, V</dc:creator>
<dc:creator>Vargas Núñez, J. A</dc:creator>
<dc:creator>Bellas Menéndez, C</dc:creator>
<dc:creator>Roldán Montaud, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento. El síndrome hipereosinófilo (SHE) es un grupo heterogéneo de procesosraros caracterizados por un aumento prominente y sostenido de eosinófilos en sangre ydaño orgánico. Se deben excluir otras causas de hipereosinofilia. Avances recientes enbiología molecular y citogenética han permitido caracterizar diferentes subtipos. Se describeun caso de la variedad linfoide.Paciente. Varón filipino de 46 años que consulta por lesiones cutáneas, fiebre, conjuntivitis,adenopatías y eosinofilia prominente.Resultados. El estudio de poblaciones linfocitarias en sangre periférica revela una poblaciónaberrante de linfocitos T (LT) CD3-CD4+ productora de interleucina 5 (IL-5). Seconfirmó la clonalidad del TCR mediante PCR.Conclusiones. La variedad linfoide del SHE está caracterizada por una expansión clonalde LT no maligna que produce IL-5, de comportamiento indolente, pero que puede evolucionara linfoma T periférico. Se describe el primer caso de variedad linfoide publicadaen nuestro país y se revisan las características de esta variedad(AU)</dc:description>
<dc:source>Rev Clin Esp;209(6): 303-308, jun.2009. ilus, tab</dc:source>
<dc:identifier>ibc-73061</dc:identifier>
<dc:title xml:lang="es">Variante linfoide del síndrome hipereosinófilo</dc:title>
<dc:subject>^d4881^s22053</dc:subject>
<dc:subject>^d808^s22032</dc:subject>
<dc:subject>^d808^s22053</dc:subject>
<dc:subject>^d31396^s22053</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d31396^s22011</dc:subject>
<dc:subject>^d13195</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d4881^s22011</dc:subject>
<dc:type>article</dc:type>
<dc:date>200906</dc:date>
</metadata>
</record>
</ibecs-document>
